Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 24824933)

1.

Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients' survival in gastric adenocarcinoma.

Giaginis C, Kourou E, Giagini A, Goutas N, Patsouris E, Kouraklis G, Theocharis S.

Neoplasma. 2014;61(3):309-17.

PMID:
24824933
2.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

3.

Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.

Zheng ZX, Sun Y, Bu ZD, Zhang LH, Li ZY, Wu AW, Wu XJ, Wang XH, Cheng XJ, Xing XF, Du H, Ji JF.

World J Gastroenterol. 2013 Dec 14;19(46):8714-21. doi: 10.3748/wjg.v19.i46.8714.

4.

Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinoma.

Giaginis C, Efkarpidis T, Alexandrou P, Patsouris E, Kouraklis G, Theocharis S.

Dis Markers. 2013;35(4):213-9. doi: 10.1155/2013/527548. Epub 2013 Sep 3.

5.

Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival.

Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G, Theocharis SE.

BMC Gastroenterol. 2009 Feb 9;9:14. doi: 10.1186/1471-230X-9-14.

6.

Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Giaginis CT, Vgenopoulou S, Tsourouflis GS, Politi EN, Kouraklis GP, Theocharis SE.

Pathol Oncol Res. 2009 Jun;15(2):173-81. doi: 10.1007/s12253-008-9120-2. Epub 2008 Nov 6.

PMID:
18987997
7.

Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy.

Kitagawa D, Taketomi A, Kayashima H, Kuroda Y, Itoh S, Yamashita Y, Maehara Y.

Oncology. 2007;72(5-6):381-7. doi: 10.1159/000113149. Epub 2008 Jan 14.

PMID:
18187960
8.

Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.

Tang P, Huang H, Chang J, Zhao GF, Lu ML, Wang Y.

World J Gastroenterol. 2013 May 7;19(17):2697-703. doi: 10.3748/wjg.v19.i17.2697.

9.
10.
11.
12.

Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).

Ferreira MA, Barcelos LS, Teixeira MM, Bakhle YS, Andrade SP.

Life Sci. 2007 Jun 27;81(3):210-7. Epub 2007 May 21.

PMID:
17588613
13.

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.

Yu JW, Zhang P, Wu JG, Wu SH, Li XQ, Wang ST, Lu RQ, Ni XC, Jiang BJ.

J Exp Clin Cancer Res. 2010 Nov 7;29:141. doi: 10.1186/1756-9966-29-141.

14.

Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.

Lukashova V, Chen Z, Duhé RJ, Rola-Pleszczynski M, Stanková J.

J Immunol. 2003 Oct 1;171(7):3794-800.

15.

Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.

Zhang L, Wang D, Jiang W, Edwards D, Qiu W, Barroilhet LM, Rho JH, Jin L, Seethappan V, Vitonis A, Wang J, Mok SC, Crum C, Cramer DW, Ye B.

Reprod Biol Endocrinol. 2010 Jun 24;8:74. doi: 10.1186/1477-7827-8-74.

16.

Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.

Wang L, Li HG, Wen JM, Peng TS, Zeng H, Wang LY.

Tumori. 2014 May-Jun;100(3):321-7. doi: 10.1700/1578.17216.

PMID:
25076245
17.
18.

IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.

Wang L, Li HG, Xia ZS, Lü J, Peng TS.

Chin Med J (Engl). 2010 Dec;123(24):3554-8.

PMID:
22166630
19.

Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type.

Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F.

World J Gastroenterol. 2007 Jul 21;13(27):3726-9.

20.

Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.

Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH.

Ann Surg Oncol. 2007 Oct;14(10):2748-58. Epub 2007 Aug 7.

PMID:
17680316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk